F773 in Nevada. Pick another state for the same tag.
Against expectation — 2023
Nevada cites F773 more often than its own record predicts
Versus expected share1.62×
1.62 times the share F773 takes of citations nationally.
Share of Nevada citations0.19%
Of every deficiency written in Nevada in 2023, this is the portion that was F773.
Nevada0.19%
National0.11%
Share of all citations that were F773.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Nevada surveyors wrote
F773 findings written in Nevada, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedFebruary 13, 2026
Based on interview, record review and document review, the facility failed to ensure an abnormal Hemoglobin A1C (HgbA1C) was communicated to and addressed by a physician for 1 of 34 sampled residents (Resident 23) and physician orders for quarterly HgbA1C blood test were carried out for 2 of 34 sampled residents (Resident 23 and 104). The deficient practice had the potential to place the residents at risk for diabetes-related complications and delayed treatment. Findings include:Resident 23 (R23) was admitted on [DATE], with diagnoses including unspecified dementia with other behavioral disturbance and diabetes mellitus. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction